Jayasree K. Iyer to attend JP Morgan 2026 Healthcare Conference in San Francisco

Amid the changing global health landscape, private capital, impact investing and innovative approaches to financing are playing an increasingly vital role in securing funding for global health.

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, will attend JP Morgan’s annual healthcare conference in San Francisco, where pharmaceutical companies are expected to outline their strategic priorities and investors will assess opportunities across the sector.

At the event, the Bay Area Global Health Alliance will host a panel, “From Products to Patients: Capturing Value in Asia’s Growth Markets” focusing on how pharmaceutical partnerships, development finance and patient platforms are creating investment opportunities in Asian markets.

Speakers will include:

• Moderator: Natasha Sunderji, Managing Director, Accenture

• Edward Booty, CEO, reach52

• Janet Dorling, Senior Vice President of Emerging Markets, Gilead Sciences

• Siddhartha Goyal, CEO, Nivi Inc.

• Nafisa Jiwani, Associate Vice President, Health Initiatives, U.S. International Development Finance Corporation

Alongside the event, Jayasree will meet with funders and investors to highlight the Access to Medicine Foundation’s work and explore potential collaborations.